[go: up one dir, main page]

CN103553931A - Method for synthesizing chiral diketone compound - Google Patents

Method for synthesizing chiral diketone compound Download PDF

Info

Publication number
CN103553931A
CN103553931A CN201310508404.7A CN201310508404A CN103553931A CN 103553931 A CN103553931 A CN 103553931A CN 201310508404 A CN201310508404 A CN 201310508404A CN 103553931 A CN103553931 A CN 103553931A
Authority
CN
China
Prior art keywords
formula
acid
methyl
butyl
compound shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310508404.7A
Other languages
Chinese (zh)
Inventor
罗三中
徐长明
张龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Chemistry CAS
Original Assignee
Institute of Chemistry CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Chemistry CAS filed Critical Institute of Chemistry CAS
Priority to CN201310508404.7A priority Critical patent/CN103553931A/en
Publication of CN103553931A publication Critical patent/CN103553931A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种合成手性二酮类化合物的方法。该方法包括:将式I所示化合物作为催化剂,与强酸在有机溶剂中混合,蒸除溶剂后将所得混合物与弱酸、式IV所示1,3-二酮和式V所示α,β-不饱和酮混匀进行Robinson反应,反应完毕得到所述式III所示化合物。该方法所用催化剂结构简单,合成路线较短,合成方法简单、易于操作。用该催化剂合成的手性二酮类化合物具有较高的产率和对映选择性,而且此合成方法采用一步法、无溶剂合成,大大降低了合成成本和合成周期,对环境友好,易于大规模生产,而且放大后产率和对映选择性都能够保持。 The invention discloses a method for synthesizing chiral diketone compounds. The method comprises: using the compound shown in formula I as a catalyst, mixing it with a strong acid in an organic solvent, distilling off the solvent, and mixing the resulting mixture with a weak acid, 1,3-diketone shown in formula IV and α,β- The unsaturated ketone is mixed to carry out the Robinson reaction, and the compound represented by the formula III is obtained after the reaction is completed. The catalyst used in the method has the advantages of simple structure, short synthesis route, simple synthesis method and easy operation. The chiral diketone compound synthesized by the catalyst has high yield and enantioselectivity, and the synthesis method adopts a one-step, solvent-free synthesis, which greatly reduces the synthesis cost and synthesis period, is environmentally friendly, and is easy to scale up. Large-scale production, and the yield and enantioselectivity can be maintained after scale-up.

Description

合成手性二酮类化合物的方法Method for synthesizing chiral diketones

技术领域technical field

本发明属于有机合成技术领域,涉及一种合成手性二酮类化合物的方法。The invention belongs to the technical field of organic synthesis, and relates to a method for synthesizing chiral diketone compounds.

背景技术Background technique

在上世纪七十年代早期,Hajos等人和Eder等人各自独立地发展了L-脯氨酸(L-proline)催化的三酮2a和2b的不对称环化反应(2a和2b由1a和1b分别与甲基乙烯基酮反应制得),立体选择性地生成双环烯酮3a和3b,这就是人们熟知的Hajos-Parrish-Eder-Sauer-Wiechert反应(如图3所示)。通常,人们将反应产物五元环并六元环的双环烯酮称之为Hajos-Parrish酮(3a,简称H-P酮),而六元环并六元环的双环烯酮称之为Wieland-Miechert酮(3b,简称W-M酮)。In the early 1970s, Hajos et al. and Eder et al. independently developed L-proline (L-proline)-catalyzed asymmetric cyclization reactions of triketones 2a and 2b (2a and 2b were composed of 1a and 1b respectively reacted with methyl vinyl ketone), stereoselectively generate bicycloketene 3a and 3b, which is the well-known Hajos-Parrish-Eder-Sauer-Wiechert reaction (as shown in Figure 3). Usually, the reaction product of five-membered ring and six-membered ring bicycloketene is called Hajos-Parrish ketone (3a, referred to as H-P ketone), and the six-membered ring and six-membered ring bicycloketene is called Wieland-Miechert Ketones (3b, referred to as W-M ketones).

手性双环烯酮是非常有用的合成砌块,在许多天然产物,尤其是萜类和类固醇类化合物的全合成中有重要的应用。例如,Danishefsky对紫杉醇骨架的合成,YamamotoH.在合成平板霉素碳骨架过程中,以及最近Bonjoch J.和Bradshaw B.等人合成(-)-Anominine的时候都用到了W-M酮及其类似物作为合成砌块。Chiral bicycloenones are very useful synthetic building blocks and have important applications in the total synthesis of many natural products, especially terpenoids and steroids. For example, Danishefsky synthesized the paclitaxel skeleton, YamamotoH. used W-M ketone and its analogues in the process of synthesizing the platymycin carbon skeleton, and recently when Bonjoch J. and Bradshaw B. et al. synthesized (-)-Anominine Synthetic blocks.

合成H-P酮,用脯氨酸催化即可达到较为理想的结果,但合成W-M酮,用脯氨酸催化只能给出中等的产率和对映选择性(70-75%ee)。为了得到对映体纯的W-M酮,一般需要后续的多级重结晶,操作繁琐,非常不经济。此外,传统的方法由于需要使用高沸点的极性非质子溶剂如DMF、DMSO等,反应后处理也较为麻烦,而且由于脯氨酸催化活性较低,反应需要加热,且反应时间较长,合成效率非常低,所有这些都不符合现代绿色化学的要求。Synthesis of H-P ketones can achieve ideal results with proline catalysis, but synthesis of W-M ketones can only give moderate yield and enantioselectivity (70-75%ee) with proline catalysis. In order to obtain enantiomerically pure W-M ketone, subsequent multi-stage recrystallization is generally required, which is cumbersome and uneconomical. In addition, due to the need to use high-boiling polar aprotic solvents such as DMF and DMSO in the traditional method, the post-reaction treatment is also relatively troublesome, and due to the low catalytic activity of proline, the reaction needs to be heated, and the reaction time is long. The efficiency is very low, all of which do not meet the requirements of modern green chemistry.

最近十年,陆续报道了很多用以合成H-P酮和W-M酮的新型手性有机小分子催化剂,它们在立体选择性和催化活性方面比脯氨酸都有了很大提高。但这些方法大多数也存在以下缺陷:首先,手性催化剂的结构复杂,合成路线较长;其次,手性催化剂用量过大(大多数都在10mol%以上),成本较高;再次,合成H-P酮和W-M酮需要多步反应和多次提纯操作,而且合成过程需要大量有机溶剂。这些缺陷都是制约其工业化生产的关键因素。因此,寻找一种结构简单、催化效率高、对映选择性好的手性催化剂及探索一种一步法(即由1a、1b直接催化合成3a、3b)、无溶剂绿色合成H-P酮、W-M酮的合成方法具有重大意义。In the last ten years, many new chiral organic small molecule catalysts for the synthesis of H-P ketones and W-M ketones have been reported successively, and their stereoselectivity and catalytic activity have been greatly improved compared with proline. However, most of these methods also have the following defects: first, the structure of the chiral catalyst is complex, and the synthetic route is relatively long; secondly, the amount of the chiral catalyst is too large (most of which are above 10mol%), and the cost is high; thirdly, the synthesis of H-P Ketones and W-M ketones require multi-step reactions and multiple purification operations, and the synthesis process requires a large amount of organic solvents. These defects are the key factors restricting its industrial production. Therefore, looking for a chiral catalyst with simple structure, high catalytic efficiency, and good enantioselectivity and exploring a one-step method (that is, direct catalytic synthesis of 3a, 3b from 1a, 1b), solvent-free green synthesis of H-P ketones, W-M ketones The synthetic method is of great significance.

发明内容Contents of the invention

本发明的目的是提供一种合成手性二酮类化合物的方法。The purpose of the present invention is to provide a method for synthesizing chiral diketones.

本发明首先提供了一种合成手性二酮类化合物时所用的催化剂,也即式I所示化合物,The present invention firstly provides a catalyst used in the synthesis of chiral diketone compounds, namely the compound shown in formula I,

Figure BDA0000401384180000021
Figure BDA0000401384180000021

所述式I中,R3、R4和R5均选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基;In the formula I, R 3 , R 4 and R 5 are all selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert Butyl, benzyl, phenyl, pyridyl, thienyl, imidazolyl, furyl and indolyl;

n2为1-9的整数,具体的,n2为1;n 2 is an integer of 1-9, specifically, n 2 is 1;

具体的,所述式I所示化合物为

Figure BDA0000401384180000022
Specifically, the compound shown in the formula I is
Figure BDA0000401384180000022

本发明提供的制备所述式I所示化合物的方法,包括如下步骤:将式II所示化合物和还原剂于有机溶剂中回流进行还原反应,反应完毕得到式I所示化合物;The method for preparing the compound represented by the formula I provided by the present invention comprises the following steps: reflux the compound represented by the formula II and a reducing agent in an organic solvent for a reduction reaction, and obtain the compound represented by the formula I after the reaction is completed;

Figure BDA0000401384180000023
Figure BDA0000401384180000023

所述式II中,R3、R4、R5的定义与分别与式I中R3、R4、R5的定义相同;In the formula II, the definitions of R 3 , R 4 , and R 5 are the same as the definitions of R 3 , R 4 , and R 5 in formula I, respectively;

n3为0-9的整数。n 3 is an integer of 0-9.

具体的,所述式II所示化合物为

Figure BDA0000401384180000024
Specifically, the compound represented by the formula II is
Figure BDA0000401384180000024

所述式II中,n3具体为0;In the formula II, n3 is specifically 0;

上述方法中,所述还原剂选自氢化锂铝、红铝溶液、B2H6、NaBH(CH3COO)3、氢化铝钠和氢化铝钾中的至少一种;In the above method, the reducing agent is selected from at least one of lithium aluminum hydride, red aluminum solution, B 2 H 6 , NaBH(CH 3 COO) 3 , sodium aluminum hydride and potassium aluminum hydride;

所述式II所示化合物、还原剂和有机溶剂的投料摩尔比为1:2-4:5-10,具体为1:3:10;The molar ratio of the compound represented by the formula II, the reducing agent and the organic solvent is 1:2-4:5-10, specifically 1:3:10;

所述还原反应步骤中,时间为1-4小时;In the reduction reaction step, the time is 1-4 hours;

所述有机溶剂选自四氢呋喃、二氯甲烷、乙醚、乙腈、甲苯和苯中的至少一种。The organic solvent is at least one selected from tetrahydrofuran, dichloromethane, ether, acetonitrile, toluene and benzene.

本发明提供的一种制备式III所示手性二酮类化合物的方法,包括如下步骤:以前述本发明提供的式I所示化合物为催化剂,与强酸在有机溶剂中混合,蒸除溶剂后将所得混合物与弱酸、式IV所示1,3-二酮和式V所示α,β-不饱和酮混匀进行Robinson反应,反应完毕得到所述式III所示化合物;A method for preparing a chiral diketone compound represented by formula III provided by the present invention comprises the following steps: using the aforementioned compound represented by formula I provided by the present invention as a catalyst, mixing it with a strong acid in an organic solvent, and distilling off the solvent Mix the obtained mixture with weak acid, 1,3-diketone represented by formula IV and α,β-unsaturated ketone represented by formula V to perform Robinson reaction, and the compound represented by formula III is obtained after the reaction is completed;

Figure BDA0000401384180000031
Figure BDA0000401384180000031

所述式III中,R1和R2均选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、烯丙基、炔丙基、丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基;In the formula III , R and R are selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, allyl, propargyl, butyl, benzyl, benzene Base, pyridyl, thienyl, imidazolyl, furyl and indolyl;

n1为0-5的整数;n 1 is an integer of 0-5;

Figure BDA0000401384180000032
Figure BDA0000401384180000032

所述式IV中,R6选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、烯丙基、炔丙基、丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基;n1为0-5的整数;In the formula IV, R is selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, allyl, propargyl, butyl, benzyl, phenyl, pyridyl , thienyl, imidazolyl, furyl and indolyl; n 1 is an integer of 0-5;

Figure BDA0000401384180000033
Figure BDA0000401384180000033

所述式V中,R7、R8和R9均选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基、吲哚基。In the formula V, R 7 , R 8 and R 9 are all selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert Butyl, benzyl, phenyl, pyridyl, thienyl, imidazolyl, furyl, indolyl.

上述方法中,所述式III和式IV中,n1具体为1、2或1-2;In the above method, in the formula III and formula IV, n 1 is specifically 1, 2 or 1-2;

所述强酸选自三氟乙酸、三氯乙酸、乙酸、三氟甲磺酸、甲磺酸、苯磺酸、含有取代基的苯磺酸、四氟硼酸、四芳基硼酸、六氟磷酸、盐酸、硫酸、硝酸、高氯酸和次氯酸中的至少一种;The strong acid is selected from trifluoroacetic acid, trichloroacetic acid, acetic acid, trifluoromethanesulfonic acid, methanesulfonic acid, benzenesulfonic acid, benzenesulfonic acid containing substituents, tetrafluoroboric acid, tetraarylboronic acid, hexafluorophosphoric acid, At least one of hydrochloric acid, sulfuric acid, nitric acid, perchloric acid and hypochlorous acid;

其中,所述含有取代基的苯磺酸中,取代基选自甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、硝基、羟基、胺基、氟原子、氯原子、溴原子、碘原子中的至少一种;Wherein, in the benzenesulfonic acid containing substituents, the substituents are selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, benzyl, nitro, hydroxyl, amine At least one of radical, fluorine atom, chlorine atom, bromine atom, iodine atom;

所述弱酸选自苯甲酸、萘甲酸、含有取代基的苯甲酸和含有取代基的萘甲酸中的至少一种,具体为间硝基苯甲酸;The weak acid is selected from at least one of benzoic acid, naphthoic acid, benzoic acid containing substituents and naphthoic acid containing substituents, specifically m-nitrobenzoic acid;

所述含有取代基的苯甲酸和萘甲酸中,取代基选自甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、硝基、羟基、胺基、氟原子、氯原子、溴原子和碘原子中的至少一种。In the benzoic acid and naphthoic acid containing substituents, the substituents are selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, benzyl, nitro, hydroxyl, amine group, fluorine atom, chlorine atom, bromine atom and iodine atom.

上述方法中,所述式I所示化合物、强酸和弱酸的投料摩尔比为1:0.5-2:0.1-2,具体为1:1:0.5;In the above method, the molar ratio of the compound represented by the formula I, the strong acid and the weak acid is 1:0.5-2:0.1-2, specifically 1:1:0.5;

式IV所示1,3-二酮和式V所示α,β-不饱和酮的投料摩尔比为1:1-5,具体为1:1.2或1:1.5或1:1.2-1.5;The molar ratio of 1,3-diketone represented by formula IV to α,β-unsaturated ketone represented by formula V is 1:1-5, specifically 1:1.2 or 1:1.5 or 1:1.2-1.5;

式I所示化合物为式IV所示1,3-二酮的投料摩尔用量的0.5-10%,具体为2%;The compound shown in formula I is 0.5-10% of the molar dosage of 1,3-diketone shown in formula IV, specifically 2%;

所述Robinson反应中,温度为20℃~100℃,具体为60℃;时间为1-6天,具体为2天、3天、5天或2-5天。In the Robinson reaction, the temperature is 20°C-100°C, specifically 60°C; the time is 1-6 days, specifically 2 days, 3 days, 5 days or 2-5 days.

具体的,式IV所示1,3-二酮为

Figure BDA0000401384180000041
Specifically, the 1,3-diketone shown in formula IV is
Figure BDA0000401384180000041

所述式V所示α,β-不饱和酮为甲基乙烯基酮

Figure BDA0000401384180000042
The α,β-unsaturated ketone represented by the formula V is methyl vinyl ketone
Figure BDA0000401384180000042

式III所示化合物为如下化合物中的任意一种:The compound shown in formula III is any one of the following compounds:

Figure BDA0000401384180000043
Figure BDA0000401384180000043

本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:

1、本发明所使用的催化剂结构简单,合成路线较短,合成方法简单、易于操作,所得手性双环烯酮类化合物具有较高的产率和对映选择性;1. The structure of the catalyst used in the present invention is simple, the synthesis route is short, the synthesis method is simple and easy to operate, and the obtained chiral bicycloketene compounds have higher yield and enantioselectivity;

2、本发明所涉及的合成手性双环烯酮的方法采用一步法合成,大大降低了合成成本和合成周期;2. The method for synthesizing chiral bicycloketene involved in the present invention adopts one-step synthesis, which greatly reduces the synthesis cost and synthesis cycle;

3、本发明所涉及的催化剂和最终产品的合成方法中采用减压蒸馏、重结晶和萃取这些易于工业化生产的方法提纯,操作简单高效;3. In the synthesis method of the catalyst involved in the present invention and the final product, these methods such as vacuum distillation, recrystallization and extraction are used for purification, and the operation is simple and efficient;

4、本发明所涉及的合成方法所用催化剂的量可以降低到2mol%,催化效率高、对映选择性好,有效降低了生产成本;4. The amount of catalyst used in the synthetic method involved in the present invention can be reduced to 2mol%, the catalytic efficiency is high, the enantioselectivity is good, and the production cost is effectively reduced;

5、本发明采用无溶剂的合成方法,绿色环保;5. The present invention adopts a solvent-free synthesis method, which is environmentally friendly;

6、本发明所涉及的方法易于大规模生产,而且放大后产率和对映选择性都能够保持。6. The method involved in the present invention is easy for large-scale production, and the yield and enantioselectivity can be maintained after amplification.

附图说明Description of drawings

图1为化合物8的1H NMR。Figure 1 is the 1 H NMR of compound 8.

图2为化合物8的13C NMR。Fig. 2 is the 13 C NMR of compound 8.

图3为Hajos-Parrish-Eder-Sauer-Wiechert反应方程式。Figure 3 is the Hajos-Parrish-Eder-Sauer-Wiechert reaction equation.

具体实施方式Detailed ways

下面结合具体实施例对本发明作进一步阐述,但本发明并不限于以下实施例。所述方法如无特别说明均为常规方法。所述原材料如无特别说明均能从公开商业途径而得。The present invention will be further described below in conjunction with specific examples, but the present invention is not limited to the following examples. The methods are conventional methods unless otherwise specified. The raw materials can be obtained from open commercial channels unless otherwise specified.

下述实施例1所用反应物化合物7是按照如下步骤制备而得:The reactant compound 7 used in the following embodiment 1 is prepared according to the following steps:

Figure BDA0000401384180000051
Figure BDA0000401384180000051

1)将氢氧化钠、L-叔亮氨酸、水按1:1:5~1:1:10的摩尔比加入反应器中,然后将和L-叔亮氨酸等摩尔量的(Boc)2O溶于5~10倍的1,4-二氧六环中,缓慢滴入反应器中,滴完后室温搅拌2~12小时。浓缩溶剂至一半后加入和浓缩后的反应液等体积的乙酸乙酯,再加入乙酸乙酯体积一半的4mol/L的盐酸,分液,有机相用等体积的水洗一次,无水硫酸钠干燥后蒸除溶剂即得化合物5。1) Add sodium hydroxide, L-tert-leucine, and water into the reactor at a molar ratio of 1:1:5 to 1:1:10, and then add (Boc ) 2 O was dissolved in 5-10 times of 1,4-dioxane, slowly dropped into the reactor, and stirred at room temperature for 2-12 hours after the drop was completed. Concentrate the solvent to half, add ethyl acetate of equal volume to the concentrated reaction solution, then add 4 mol/L hydrochloric acid half of the volume of ethyl acetate, separate the layers, wash the organic phase once with an equal volume of water, and dry over anhydrous sodium sulfate The solvent was evaporated to obtain compound 5.

2)将化合物5和干燥的二氯甲烷按1:5~1:10的摩尔比加入反应器中,然后在冰水浴下缓慢滴加和化合物5等摩尔量的DCC(N,N’-二环己基碳二亚胺)的二氯甲烷溶液,滴完后再加入和化合物5等摩尔量的二乙胺,滴完后室温搅拌2~12小时。过滤除去白色沉淀,有机相分别用和反应液等体积的2%盐酸、4%碳酸氢钠、饱和食盐水洗涤,无水硫酸钠干燥后蒸除溶剂即得化合物6。2) Add compound 5 and dry dichloromethane into the reactor at a molar ratio of 1:5 to 1:10, and then slowly add DCC (N,N'-di Cyclohexylcarbodiimide) dichloromethane solution, and then add diethylamine in an equimolar amount to compound 5 after dropping, and stir at room temperature for 2 to 12 hours after dropping. The white precipitate was removed by filtration, and the organic phase was washed with 2% hydrochloric acid, 4% sodium bicarbonate, and saturated brine respectively, dried over anhydrous sodium sulfate, and evaporated to obtain compound 6.

3)将化合物6和无水甲醇按1:5~1:10的摩尔比加入反应器中,然后缓慢滴加化合物6摩尔量1~5倍的乙酰氯,加热回流1~5小时后蒸除溶剂,再加入和甲醇等体积的二氯甲烷和水,用碳酸钾调节水相pH值至弱碱性后分出有机相。有机相中加入等体积的水,用稀盐酸调节水相pH值至弱酸性后分出水相。水相中加入等体积的二氯甲烷,再用碳酸钾调节水相pH值至弱碱性,分出有机相,无水硫酸钠干燥后蒸除溶剂即得化合物7。3) Add compound 6 and anhydrous methanol into the reactor at a molar ratio of 1:5 to 1:10, then slowly add acetyl chloride 1 to 5 times the molar amount of compound 6 dropwise, heat and reflux for 1 to 5 hours and then evaporate Solvent, then add dichloromethane and water equal to the volume of methanol, adjust the pH value of the aqueous phase to weak alkalinity with potassium carbonate, and separate the organic phase. An equal volume of water was added to the organic phase, and the pH value of the aqueous phase was adjusted to weak acidity with dilute hydrochloric acid, and then the aqueous phase was separated. An equal volume of dichloromethane was added to the aqueous phase, and the pH value of the aqueous phase was adjusted to weak alkaline with potassium carbonate, the organic phase was separated, dried over anhydrous sodium sulfate, and the solvent was evaporated to obtain compound 7.

实施例1、制备式I所示化合物(也即化合物8)Embodiment 1, preparation of the compound shown in formula I (ie compound 8)

反应流程如下:The reaction process is as follows:

Figure BDA0000401384180000061
Figure BDA0000401384180000061

将归属式II所示化合物的化合物7(n3=0,R3为叔丁基,R4和R5均为乙基)和干燥的四氢呋喃按1:10的摩尔比加入反应器中,然后在冰水浴下缓慢化合物7摩尔量3倍的还原剂氢化锂铝,加热回流进行还原反应4小时后冷却至室温。在冰水浴下滴加四氢呋喃体积量一半的饱和硫酸钠水溶液,加完后过滤除去沉淀,滤液用等体积的乙酸乙酯萃取,无水硫酸钠干燥后蒸除溶剂,再用油泵减压蒸馏即得式I所示化合物8;Compound 7 (n 3 =0, R 3 is tert-butyl, R 4 and R 5 are both ethyl) and dry tetrahydrofuran are added to the reactor at a molar ratio of 1:10, and then In an ice-water bath, the reducing agent lithium aluminum hydride, which is 3 times the molar amount of compound 7, is heated to reflux for reduction reaction for 4 hours and then cooled to room temperature. Under an ice-water bath, add a saturated aqueous solution of sodium sulfate with half the volume of tetrahydrofuran dropwise. After the addition, filter to remove the precipitate. Compound 8 shown in formula I is obtained;

其核磁数据如下(谱图如图1和2所示):1H NMR(300MHz,CDCl3):2.67-2.53(m,3H),2.45-2.34(m,3H),2.15-2.07(m,1H),1.49(br,2H),0.99(t,J=6.90Hz,6H),0.89(s,9H);13C NMR(75MHz,CDCl3):57.4,55.6,47.5,33.2,26.4,12.2.Its NMR data are as follows (the spectrograms are shown in Figures 1 and 2): 1 H NMR(300MHz, CDCl 3 ):2.67-2.53(m,3H),2.45-2.34(m,3H),2.15-2.07(m, 1H),1.49(br,2H),0.99(t,J=6.90Hz,6H),0.89(s,9H); 13 C NMR(75MHz,CDCl 3 ):57.4,55.6,47.5,33.2,26.4,12.2 .

比旋光度[α]D 20=+124.1(c=0.50,MeOH).Specific rotation[α] D 20 =+124.1(c=0.50,MeOH).

由上可知,该产物结构正确,为归属于式I的化合物,其中,n2为1,R3为叔丁基,R4和R5均为乙基。It can be seen from the above that the product has a correct structure and is a compound belonging to formula I, wherein n2 is 1, R3 is tert-butyl, and R4 and R5 are both ethyl groups.

实施例2Example 2

Figure BDA0000401384180000062
Figure BDA0000401384180000062

1)将1,3-环己二酮(150mmol)溶于氢氧化钠水溶液(5M,30mL)中,加入碘甲烷(200mmol),加热至65℃反应24h。冷却后过滤所得白色固体即得归属式IV的2-甲基-1,3-环己二酮(n1为2,R6为甲基),产率65%。1) Dissolve 1,3-cyclohexanedione (150mmol) in aqueous sodium hydroxide solution (5M, 30mL), add iodomethane (200mmol), and heat to 65°C for 24h. After cooling, the resulting white solid was filtered to obtain 2-methyl-1,3-cyclohexanedione (n 1 is 2, R 6 is methyl) belonging to formula IV, with a yield of 65%.

2)将2-甲基-1,3-环己二酮(50mmol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(60mmol)加入反应器中,再将实施例1制备所得催化剂化合物8(1mmol)用1ml有机溶剂二氯甲烷溶解,滴入强酸三氟甲磺酸(1mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入弱酸间硝基苯甲酸(0.5mmol),加热至60℃,机械搅拌进行Robinson反应3天后,反应完成,用油泵减压蒸馏即得W-M酮,产率83%,ee值90%。2) Add 2-methyl-1,3-cyclohexanedione (50mmol) and methyl vinyl ketone belonging to formula V (R 7 and R 9 are both methyl groups, R 8 is a hydrogen atom) (60mmol) In the reactor, the catalyst compound 8 (1mmol) prepared in Example 1 was dissolved with 1ml of organic solvent dichloromethane, and the strong acid trifluoromethanesulfonic acid (1mmol) was added dropwise, and the catalyst was added to the reactor after distilling off the dichloromethane Add the weak acid m-nitrobenzoic acid (0.5mmol) at the end, heat to 60°C, and carry out Robinson reaction with mechanical stirring for 3 days. After the reaction is complete, use an oil pump to distill under reduced pressure to obtain WM ketone, with a yield of 83% and an ee value of 90%. .

W-M酮核磁数据如下:1H NMR(300MHz,CDCl3):δ(ppm)=5.83(s,1H),2.65-2.76(m,2H),2.41-2.52(m,4H),2.08-2.17(m,3H),1.69(m,1H),1.43(s,3H);13CNMR(100MHz,CDCl3):211.0,198.3,165.8,125.8,50.6,37.6,33.6,31.7,29.6,23.3,22.9.The NMR data of WM ketone are as follows: 1 H NMR (300MHz, CDCl 3 ): δ (ppm) = 5.83 (s, 1H), 2.65-2.76 (m, 2H), 2.41-2.52 (m, 4H), 2.08-2.17 ( m,3H),1.69(m,1H),1.43(s,3H); 13 CNMR(100MHz,CDCl 3 ):211.0,198.3,165.8,125.8,50.6,37.6,33.6,31.7,29.6,23.3,22.9.

其比旋光度[α]D 20=-13(c=0.5,CHCl3).其ee值由高效液相色谱测定[DaicelChiralpak OD-H column,λ=254nm,2-propanol:n-Hexane=3:97,flow rate=0.8mL/min]:tR=35.47min(minor),tR=38.24min(major).Its specific rotation [α] D 20 =-13 (c=0.5, CHCl 3 ). Its ee value is determined by high performance liquid chromatography [DaicelChiralpak OD-H column, λ=254nm, 2-propanol:n-Hexane=3 :97,flow rate=0.8mL/min]:t R =35.47min(minor),t R =38.24min(major).

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为甲基,R2为氢,n1为2。As can be seen from the above, the product has a correct structure and is the target compound shown in formula III, wherein R 1 is methyl, R 2 is hydrogen, and n 1 is 2.

实施例3Example 3

1)将1,3-环戊二酮(20mmol)溶于氢氧化钠水溶液(5M,4mL)中,加入四丁基溴化铵(2mmol)和碘甲烷(40mmol),加热至65℃反应24h。冷却后加入稀盐酸(15mL),用乙酸乙酯(15mL×3)萃取三次,无水硫酸钠干燥,蒸除溶剂后柱层析即得归属式IV的2-甲基-1,3-环戊二酮(n1为1,R6为甲基),产率45%。1) Dissolve 1,3-cyclopentanedione (20mmol) in aqueous sodium hydroxide solution (5M, 4mL), add tetrabutylammonium bromide (2mmol) and methyl iodide (40mmol), heat to 65°C for 24h . After cooling, add dilute hydrochloric acid (15mL), extract three times with ethyl acetate (15mL×3), dry over anhydrous sodium sulfate, evaporate the solvent and perform column chromatography to obtain 2-methyl-1,3-cyclo Pentanedione (n 1 is 1, R 6 is methyl), yield 45%.

2)将步骤1)所得2-甲基-1,3-环戊二酮(10mmol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(15mmol)加入反应器中,再将实施例1制备所得催化剂化合物8(0.2mmol)用0.5ml二氯甲烷溶解,滴入三氟甲磺酸(0.2mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入间硝基苯甲酸(0.1mmol),加热至60℃,磁力搅拌进行Robinson反应5天后,反应完成,用石油醚:乙酸乙酯=2:1柱层析即得H-P酮,产率80%,ee值76%。2) Combine 2-methyl-1,3-cyclopentadione (10mmol) obtained in step 1) and methyl vinyl ketone belonging to formula V (R 7 and R 9 are both methyl groups, R 8 is a hydrogen atom) (15mmol) was added in the reactor, then the catalyst compound 8 (0.2mmol) prepared in Example 1 was dissolved with 0.5ml dichloromethane, dripped into trifluoromethanesulfonic acid (0.2mmol), and the dichloromethane was evaporated Add the catalyst into the reactor, add m-nitrobenzoic acid (0.1mmol) at the end, heat to 60°C, and carry out Robinson reaction with magnetic stirring for 5 days. After the reaction is complete, use petroleum ether: ethyl acetate = 2:1 column chromatography to obtain HP ketone, yield 80%, ee value 76%.

H-P酮核磁数据如下:1H NMR(300MHz,CDCl3):δ(ppm)=5.96(s,1H),3.05-2.92(m,1H),2.86-2.75(m,2H),2.60-2.38(m,3H),2.20-2.09(m,1H),1.91-1.80(m,1H),1.34(s,3H);13C NMR(100MHz,CDCl3):216.4,198.0,169.7,123.8,48.6,35.8,32.9,29.2,26.8,20.5.The NMR data of HP ketone are as follows: 1 H NMR (300MHz, CDCl 3 ): δ(ppm)=5.96(s,1H),3.05-2.92(m,1H),2.86-2.75(m,2H),2.60-2.38( m,3H),2.20-2.09(m,1H),1.91-1.80(m,1H),1.34(s,3H); 13 C NMR(100MHz,CDCl 3 ):216.4,198.0,169.7,123.8,48.6, 35.8, 32.9, 29.2, 26.8, 20.5.

其比旋光度[α]D 20=-150(c=0.5,CHCl3).其ee值由高效液相色谱测定[DaicelChiralpak AD-H column,λ=254nm,2-propanol:n-Hexane=1:9,flow rate=1.0mL/min]:tR=10.09min(minor),tR=10.53min(major).Its specific rotation [α] D 20 =-150 (c=0.5, CHCl 3 ). Its ee value is determined by high performance liquid chromatography [DaicelChiralpak AD-H column, λ=254nm, 2-propanol:n-Hexane=1 :9,flow rate=1.0mL/min]:t R =10.09min(minor),t R =10.53min(major).

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为甲基,R2为氢,n1为1。As can be seen from the above, the product has a correct structure and is the target compound shown in formula III, wherein R 1 is methyl, R 2 is hydrogen, and n 1 is 1.

实施例4Example 4

Figure BDA0000401384180000081
Figure BDA0000401384180000081

1)将1,3-环己二酮(20mmol)溶于氢氧化钠水溶液(5M,4mL)中,加入铜粉(0.1g)和溴丙烯(24mmol),室温搅拌8h后过滤,将所得沉淀用甲醇溶解后再过滤除去铜粉,蒸除甲醇后柱层析,得白色固体即得归属式IV的2-烯丙基-1,3-环己二酮(n1为2,R6为烯丙基),产率54%。1) Dissolve 1,3-cyclohexanedione (20mmol) in aqueous sodium hydroxide solution (5M, 4mL), add copper powder (0.1g) and allyl bromide (24mmol), stir at room temperature for 8h and filter, and the resulting precipitate Dissolved with methanol and then filtered to remove copper powder, evaporated to remove methanol and then column chromatography to obtain a white solid that is 2-allyl-1,3-cyclohexanedione belonging to formula IV (n 1 is 2, R 6 is Allyl), yield 54%.

2)将2-烯丙基-1,3-环己二酮(10mmol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(12mmol)加入反应器中,再将实施例1制备所得催化剂化合物8(0.2mmol)用0.5ml二氯甲烷溶解,滴入三氟甲磺酸(0.2mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入间硝基苯甲酸(0.1mmol),加热至60℃,机械搅拌进行Robinson反应3天后,反应完成,用石油醚:乙酸乙酯=2:1柱层析即得目标产物,产率84%,ee值88%。2) 2-allyl-1,3-cyclohexanedione (10mmol) and methyl vinyl ketone belonging to formula V (R 7 and R 9 are both methyl groups, R 8 is a hydrogen atom) (12mmol) Add in the reactor, then dissolve the catalyst compound 8 (0.2mmol) prepared in Example 1 with 0.5ml of dichloromethane, drop trifluoromethanesulfonic acid (0.2mmol), and add the catalyst to the reaction after distilling off the dichloromethane Finally, add m-nitrobenzoic acid (0.1mmol), heat to 60°C, and perform Robinson reaction with mechanical stirring for 3 days. After the reaction is complete, use petroleum ether: ethyl acetate = 2:1 column chromatography to obtain the target product. Yield 84%, ee value 88%.

1H NMR(300MHz,CDCl3):δ(ppm)=5.90(s,1H),,5.89-5.54(m,1H),5.16(d,J=16.0Hz,1H),5.12(d,J=8.5Hz,1H,),2.81-2.38(m,8H),2.25-1.99(m,3H),1.76-1.66(m,1H);13C NMR(75MHz,CDCl3):δ(ppm)=209.1,198.2,164.9,131.6,126.5,119.5,54.7,39.9,38.4,33.3,31.9,26.2,23.3. 1 H NMR (300MHz, CDCl 3 ): δ(ppm)=5.90(s,1H),,5.89-5.54(m,1H),5.16(d,J=16.0Hz,1H),5.12(d,J= 8.5Hz,1H,),2.81-2.38(m,8H),2.25-1.99(m,3H),1.76-1.66(m,1H); 13 C NMR(75MHz,CDCl 3 ):δ(ppm)=209.1 ,198.2,164.9,131.6,126.5,119.5,54.7,39.9,38.4,33.3,31.9,26.2,23.3.

其比旋光度[α]D 20=-43(c=0.5,CHCl3).其ee值由高效液相色谱测定[DaicelChiralpak OD-H column,λ=254nm,2-propanol:n-Hexane=1:19,flow rate=1.0mL/min]:tR=14.89min(major),tR=16.29min(minor).Its specific rotation [α] D 20 =-43 (c=0.5, CHCl3). Its ee value is determined by high performance liquid chromatography [DaicelChiralpak OD-H column, λ=254nm, 2-propanol:n-Hexane=1: 19, flow rate=1.0mL/min]:t R =14.89min(major),t R =16.29min(minor).

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为-CH2CH=CH2,R2为氢,n1为2。It can be known from the above that the product has a correct structure and is the target compound shown in formula III, wherein R 1 is -CH 2 CH=CH 2 , R 2 is hydrogen, and n 1 is 2.

实施例5Example 5

Figure BDA0000401384180000091
Figure BDA0000401384180000091

1)将1,3-环己二酮(20mmol)溶于甲醇(20mL)中,加入甲醇钠(20mmol)和炔丙基溴(24mmol),加热至60℃反应24h。冷却后蒸除甲醇,加入水(15mL),用二氯甲烷(15mL×3)萃取三次,无水硫酸钠干燥,蒸除溶剂后柱层析即得归属式IV的2-炔丙基-1,3-环己二酮(n1为2,R6为炔丙基),产率42%。1) Dissolve 1,3-cyclohexanedione (20mmol) in methanol (20mL), add sodium methoxide (20mmol) and propargyl bromide (24mmol), and heat to 60°C for 24h. After cooling, distill off methanol, add water (15mL), extract three times with dichloromethane (15mL×3), dry over anhydrous sodium sulfate, evaporate the solvent and perform column chromatography to obtain 2-propargyl-1 of formula IV , 3-cyclohexanedione (n 1 is 2, R 6 is propargyl), the yield is 42%.

2)将2-炔丙基-1,3-环己二酮(10mmol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(12mmol)加入反应器中,再将实施例1制备所得催化剂化合物8(0.2mmol)用0.5ml二氯甲烷溶解,滴入三氟甲磺酸(0.2mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入间硝基苯甲酸(0.1mmol),加热至60℃,磁力搅拌进行Robinson反应3天后,反应完成,用石油醚:乙酸乙酯=2:1柱层析即得目标产物,产率81%,ee值92%。2) Mix 2-propargyl-1,3-cyclohexanedione (10mmol) and methyl vinyl ketone belonging to formula V (R 7 and R 9 are both methyl groups, R 8 is a hydrogen atom) (12mmol) Add in the reactor, then dissolve the catalyst compound 8 (0.2mmol) prepared in Example 1 with 0.5ml of dichloromethane, drop trifluoromethanesulfonic acid (0.2mmol), and add the catalyst to the reaction after distilling off the dichloromethane Finally, add m-nitrobenzoic acid (0.1mmol), heat to 60°C, and carry out Robinson reaction with magnetic stirring for 3 days. After the reaction is complete, use petroleum ether: ethyl acetate = 2:1 column chromatography to obtain the target product. Yield 81%, ee value 92%.

1H NMR(300MHz,CDCl3):δ=5.92(d,J=1.6Hz,1H),2.82-2.66(m,4H),2.58-2.45(m,4H),2.35(dt,J=14.4,4.6Hz,1H),2.20-2.10(m,3H),1.72(qt,J=13.4,4.4Hz,1H);13C NMR(100MHz,CDCl3):δ=208.0,197.8,163.0,127.3,78.0,73.3,53.5,38.1,33.5,31.9,27.3,26.1,23.2. 1 H NMR (300MHz, CDCl 3 ): δ=5.92(d, J=1.6Hz, 1H), 2.82-2.66(m, 4H), 2.58-2.45(m, 4H), 2.35(dt, J=14.4, 4.6Hz,1H),2.20-2.10(m,3H),1.72(qt,J=13.4,4.4Hz,1H); 13 C NMR(100MHz,CDCl 3 ):δ=208.0,197.8,163.0,127.3,78.0 ,73.3,53.5,38.1,33.5,31.9,27.3,26.1,23.2.

其比旋光度[α]D 20=-18(c=0.5,CHCl3).其ee值由高效液相色谱测定[DaicelChiralpak AD-H column,λ=254nm,2-propanol:n-Hexane=1:9,flow rate=1.0mL/min]:tR=13.05min(major),tR=13.95min(minor).Its specific rotation [α] D 20 =-18 (c=0.5, CHCl 3 ). Its ee value is determined by high performance liquid chromatography [DaicelChiralpak AD-H column, λ=254nm, 2-propanol:n-Hexane=1 :9,flow rate=1.0mL/min]:t R =13.05min(major),t R =13.95min(minor).

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为-CH2C≡CH,R2为氢,n1为2。It can be known from the above that the product has a correct structure and is the target compound shown in formula III, wherein R 1 is -CH 2 C≡CH, R 2 is hydrogen, and n 1 is 2.

实施例6Example 6

Figure BDA0000401384180000101
Figure BDA0000401384180000101

将2-甲基-1,3-环己二酮(50mmol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(60mmol)加入反应器中,再将实施例1制备所得催化剂化合物8(2.5mmol)用1ml二氯甲烷溶解,滴入三氟甲磺酸(2.5mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入间硝基苯甲酸(2.5mmol),室温搅拌进行Robinson反应10h后反应完成,用油泵减压蒸馏即得W-M酮,产率85%,ee值92%。Add 2-methyl-1,3-cyclohexanedione (50mmol) and methyl vinyl ketone belonging to formula V ( R7 and R9 are both methyl groups, R8 is a hydrogen atom) (60mmol) into the reactor , then dissolve the catalyst compound 8 (2.5mmol) obtained in Example 1 with 1ml of dichloromethane, drop trifluoromethanesulfonic acid (2.5mmol), and add the catalyst into the reactor after distilling off the dichloromethane, and finally Add m-nitrobenzoic acid (2.5mmol), stir at room temperature and carry out Robinson reaction for 10h. After the reaction is complete, use an oil pump to distill under reduced pressure to obtain WM ketone, with a yield of 85% and an ee value of 92%.

该产物的结构确认结果与实施例2相同,不再赘述。The structure confirmation result of this product is the same as that of Example 2, and will not be repeated here.

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为甲基,R2为氢,n1为2。As can be seen from the above, the product has a correct structure and is the target compound shown in formula III, wherein R 1 is methyl, R 2 is hydrogen, and n 1 is 2.

实施例7Example 7

Figure BDA0000401384180000111
Figure BDA0000401384180000111

将2-甲基-1,3-环己二酮(1.0mol)和归属式V的甲基乙烯基酮(R7和R9均为甲基,R8为氢原子)(1.2mol)加入反应器中,再将实施例1制备所得催化剂化合物8(20mmol)用10ml二氯甲烷溶解,滴入三氟甲磺酸(20mmol),蒸除二氯甲烷后将此催化剂加入反应器中,最后加入间硝基苯甲酸(10mmol),加热至60℃,机械搅拌进行Robinson反应2天后,反应完成,用油泵减压蒸馏即得W-M酮,产率90%,ee值90%。再用乙酸乙酯和正己烷的混合溶剂重结晶后得ee值大于99%的产品。Add 2-methyl-1,3-cyclohexanedione (1.0mol) and methyl vinyl ketone belonging to formula V ( R7 and R9 are both methyl groups, R8 is a hydrogen atom) (1.2mol) In the reactor, the obtained catalyst compound 8 (20mmol) prepared in Example 1 was dissolved with 10ml of dichloromethane, and trifluoromethanesulfonic acid (20mmol) was added dropwise. After dichloromethane was evaporated, the catalyst was added to the reactor, and finally Add m-nitrobenzoic acid (10mmol), heat to 60°C, and mechanically stir for Robinson reaction for 2 days. After the reaction is complete, use an oil pump to distill under reduced pressure to obtain WM ketone, with a yield of 90% and an ee value of 90%. Recrystallize with a mixed solvent of ethyl acetate and n-hexane to obtain a product with an ee value greater than 99%.

该产物的结构确认结果与实施例2相同,不再赘述。The structure confirmation result of this product is the same as that of Example 2, and will not be repeated here.

由上可知,该产物结构正确,为式III所示目标化合物,其中,R1为甲基,R2为氢,n1为2。As can be seen from the above, the product has a correct structure and is the target compound shown in formula III, wherein R 1 is methyl, R 2 is hydrogen, and n 1 is 2.

Claims (10)

1.式I所示化合物,1. the compound shown in formula I,
Figure FDA0000401384170000011
Figure FDA0000401384170000011
所述式I中,R3、R4和R5均选自氢原子、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基中的任意一种;In the formula I, R 3 , R 4 and R 5 are all selected from hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, benzyl, phenyl, Any one of pyridyl, thienyl, imidazolyl, furyl and indolyl; n2为1-9的整数。n 2 is an integer of 1-9.
2.根据权利要求1所述的化合物,其特征在于:所述式I所示化合物为
Figure FDA0000401384170000012
2. The compound according to claim 1, characterized in that: the compound shown in the formula I is
Figure FDA0000401384170000012
3.一种制备权利要求1或2所述式I所示化合物的方法,包括如下步骤:将式II所示化合物和还原剂于有机溶剂中回流进行还原反应,反应完毕得到式I所示化合物;3. A method for preparing the compound shown in the formula I described in claim 1 or 2, comprising the steps of: the compound shown in the formula II and the reducing agent are refluxed in an organic solvent to carry out a reduction reaction, and the reaction is completed to obtain the compound shown in the formula I ;
Figure FDA0000401384170000013
Figure FDA0000401384170000013
所述式II中,R3、R4、R5的定义与分别与式I中R3、R4、R5的定义相同;In the formula II, the definitions of R 3 , R 4 , and R 5 are the same as the definitions of R 3 , R 4 , and R 5 in formula I, respectively; n3为0-9的整数。n 3 is an integer of 0-9.
4.根据权利要求3所述的方法,其特征在于:所述式II所示化合物为
Figure FDA0000401384170000014
4. The method according to claim 3, characterized in that: the compound shown in the formula II is
Figure FDA0000401384170000014
5.根据权利要求3或4所述的方法,其特征在于:所述还原剂选自氢化锂铝、红铝溶液、B2H6、NaBH(CH3COO)3、氢化铝钠和氢化铝钾中的至少一种;5. The method according to claim 3 or 4, characterized in that: the reducing agent is selected from lithium aluminum hydride, red aluminum solution, B2H6 , NaBH( CH3COO ) 3 , sodium aluminum hydride and aluminum hydride at least one of potassium; 所述式II所示化合物、还原剂和有机溶剂的投料摩尔比为1:2-4:5-10,具体为1:3:10;The molar ratio of the compound represented by the formula II, the reducing agent and the organic solvent is 1:2-4:5-10, specifically 1:3:10; 所述还原反应步骤中,时间为1-4小时;In the reduction reaction step, the time is 1-4 hours; 所述有机溶剂选自四氢呋喃、二氯甲烷、乙醚、乙腈、甲苯和苯中的至少一种。The organic solvent is at least one selected from tetrahydrofuran, dichloromethane, ether, acetonitrile, toluene and benzene. 6.一种制备式III所示化合物的方法,包括如下步骤:以权利要求1或2任一所述式I所示化合物作为催化剂,与强酸在有机溶剂中混合,蒸除溶剂后将所得混合物与弱酸、式IV所示1,3-二酮和式V所示α,β-不饱和酮混匀进行Robinson反应,反应完毕得到所述式III所示化合物;6. A method for the compound shown in the preparation formula III, comprising the steps of: using the compound shown in the arbitrary formula I of claim 1 or 2 as a catalyzer, mixing it with a strong acid in an organic solvent, and distilling the resulting mixture after removing the solvent Mix with weak acid, 1,3-diketone shown in formula IV and α, β-unsaturated ketone shown in formula V to carry out Robinson reaction, and the compound shown in formula III is obtained after the reaction is completed;
Figure FDA0000401384170000021
Figure FDA0000401384170000021
所述式III中,R1和R2均选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、烯丙基、炔丙基、丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基;In the formula III , R and R are selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, allyl, propargyl, butyl, benzyl, benzene Base, pyridyl, thienyl, imidazolyl, furyl and indolyl; n1为0-5的整数;n 1 is an integer of 0-5; 所述式IV中,R6选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、烯丙基、炔丙基、丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基;n1为0-5的整数;In the formula IV, R is selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, allyl, propargyl, butyl, benzyl, phenyl, pyridyl , thienyl, imidazolyl, furyl and indolyl; n 1 is an integer of 0-5;
Figure FDA0000401384170000023
Figure FDA0000401384170000023
所述式V中,R7、R8和R9均选自如下基团中的任意一种:氢原子、甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、苯基、吡啶基、噻吩基、咪唑基、呋喃基和吲哚基。In the formula V, R 7 , R 8 and R 9 are all selected from any one of the following groups: hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert Butyl, benzyl, phenyl, pyridyl, thienyl, imidazolyl, furyl and indolyl.
7.根据权利要求6所述的方法,其特征在于:所述强酸选自三氟乙酸、三氯乙酸、乙酸、三氟甲磺酸、甲磺酸、苯磺酸、含有取代基的苯磺酸、四氟硼酸、四芳基硼酸、盐酸、硫酸、硝酸、六氟磷酸、高氯酸和次氯酸中的至少一种;7. The method according to claim 6, characterized in that: the strong acid is selected from trifluoroacetic acid, trichloroacetic acid, acetic acid, trifluoromethanesulfonic acid, methanesulfonic acid, benzenesulfonic acid, benzenesulfonic acid containing substituents At least one of acid, tetrafluoroboric acid, tetraarylboronic acid, hydrochloric acid, sulfuric acid, nitric acid, hexafluorophosphoric acid, perchloric acid and hypochlorous acid; 其中,所述含有取代基的苯磺酸中,取代基选自甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、硝基、羟基、胺基、氟原子、氯原子、溴原子和碘原子中的至少一种;Wherein, in the benzenesulfonic acid containing substituents, the substituents are selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, benzyl, nitro, hydroxyl, amine At least one of radical, fluorine atom, chlorine atom, bromine atom and iodine atom; 所述弱酸选自苯甲酸、萘甲酸、含有取代基的苯甲酸和含有取代基的萘甲酸中的至少一种,具体为间硝基苯甲酸;The weak acid is selected from at least one of benzoic acid, naphthoic acid, benzoic acid containing substituents and naphthoic acid containing substituents, specifically m-nitrobenzoic acid; 所述含有取代基的苯甲酸和萘甲酸中,取代基选自甲基、乙基、丙基、异丙基、丁基、异丁基、叔丁基、苄基、硝基、羟基、胺基、氟原子、氯原子、溴原子和碘原子中的至少一种。In the benzoic acid and naphthoic acid containing substituents, the substituents are selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, benzyl, nitro, hydroxyl, amine group, fluorine atom, chlorine atom, bromine atom and iodine atom. 8.根据权利要求6或7所述的方法,其特征在于:所述式I所示化合物、强酸和弱酸的投料摩尔比为1:0.5-2:0.1-2,具体为1:1:0.5;8. The method according to claim 6 or 7, characterized in that: the molar ratio of the compound shown in formula I, strong acid and weak acid is 1:0.5-2:0.1-2, specifically 1:1:0.5 ; 式IV所示1,3-二酮和式V所示α,β-不饱和酮的投料摩尔比为1:1-5,具体为1:1.2或1:1.5或1:1.2-1.5;The molar ratio of 1,3-diketone represented by formula IV to α,β-unsaturated ketone represented by formula V is 1:1-5, specifically 1:1.2 or 1:1.5 or 1:1.2-1.5; 式I所示化合物为式IV所示1,3-二酮的投料摩尔用量的0.5-10%,具体为2%;The compound shown in formula I is 0.5-10% of the molar dosage of 1,3-diketone shown in formula IV, specifically 2%; 所述Robinson反应中,温度为20℃~100℃,具体为60℃;In the Robinson reaction, the temperature is 20°C to 100°C, specifically 60°C; 时间为5小时-6天,具体为10小时、2天、3天、5天或2-5天。The time is 5 hours-6 days, specifically 10 hours, 2 days, 3 days, 5 days or 2-5 days. 9.根据权利要求6-8任一所述的方法,其特征在于:所述式IV所示1,3-二酮为2-甲基-1,3-环戊二酮或2-甲基-1,3-环己二酮;或2-烯丙基-1,3-环己二酮,2-炔丙基-1,3-环己二酮、2-苄基-1,3-环己二酮、2-苯基-1,3-环己二酮;9. The method according to any one of claims 6-8, characterized in that: the 1,3-diketone shown in the formula IV is 2-methyl-1,3-cyclopentanedione or 2-methyl -1,3-cyclohexanedione; or 2-allyl-1,3-cyclohexanedione, 2-propargyl-1,3-cyclohexanedione, 2-benzyl-1,3- Cyclohexanedione, 2-phenyl-1,3-cyclohexanedione; 所述式V所示α,β-不饱和酮为甲基乙烯基酮或乙基乙烯基酮。The α,β-unsaturated ketone represented by the formula V is methyl vinyl ketone or ethyl vinyl ketone. 10.根据权利要求6-9任一所述的方法,其特征在于:所示式III所示化合物为如下化合物中的任意一种:10. The method according to any one of claims 6-9, characterized in that: the compound shown in formula III is any one of the following compounds:
Figure FDA0000401384170000031
Figure FDA0000401384170000031
CN201310508404.7A 2013-10-24 2013-10-24 Method for synthesizing chiral diketone compound Pending CN103553931A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310508404.7A CN103553931A (en) 2013-10-24 2013-10-24 Method for synthesizing chiral diketone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310508404.7A CN103553931A (en) 2013-10-24 2013-10-24 Method for synthesizing chiral diketone compound

Publications (1)

Publication Number Publication Date
CN103553931A true CN103553931A (en) 2014-02-05

Family

ID=50008346

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310508404.7A Pending CN103553931A (en) 2013-10-24 2013-10-24 Method for synthesizing chiral diketone compound

Country Status (1)

Country Link
CN (1) CN103553931A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541582A (en) * 2016-01-07 2016-05-04 浙江大学 MBH reaction of alpha, beta-unsaturated ketone and allyl acetate
CN107325025A (en) * 2017-07-17 2017-11-07 中国科学院化学研究所 A kind of chiral alpha amino acid derivativges and preparation method thereof
CN108101811A (en) * 2016-11-25 2018-06-01 斯福瑞(南通)制药有限公司 The method for producing N- tertbutyloxycarbonyl -2- amino -3,3- acid dimethyls
CN109776293A (en) * 2019-01-25 2019-05-21 温州大学 A kind of method for preparing 1,3-diketone compound with acetylenone

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103360341A (en) * 2012-03-30 2013-10-23 华东理工大学 Tertiary leucine derived chiral amine compound as well as preparation method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103360341A (en) * 2012-03-30 2013-10-23 华东理工大学 Tertiary leucine derived chiral amine compound as well as preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHENSHEN HU ET AL.: "Chiral Primary Amine Catalyzed Asymmetric Direct Cross-Aldol Reaction of Acetaldehyde", 《EUROPEAN JOURNAL OF ORGANIC CHEMISTRY》 *
XU, CHANGMING ET AL.: "A practical protocol for asymmetric synthesis of Wieland-Miescher and Hajos-Parrish ketones catalyzed by a simple chiral primary amine", 《SYNTHESIS》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541582A (en) * 2016-01-07 2016-05-04 浙江大学 MBH reaction of alpha, beta-unsaturated ketone and allyl acetate
CN105541582B (en) * 2016-01-07 2017-07-18 浙江大学 The MBH of alpha, beta unsaturated ketone and allyl acetic acid ester reacts
CN108101811A (en) * 2016-11-25 2018-06-01 斯福瑞(南通)制药有限公司 The method for producing N- tertbutyloxycarbonyl -2- amino -3,3- acid dimethyls
CN107325025A (en) * 2017-07-17 2017-11-07 中国科学院化学研究所 A kind of chiral alpha amino acid derivativges and preparation method thereof
CN107325025B (en) * 2017-07-17 2019-04-09 中国科学院化学研究所 A kind of chiral α-amino acid derivative and preparation method thereof
CN109776293A (en) * 2019-01-25 2019-05-21 温州大学 A kind of method for preparing 1,3-diketone compound with acetylenone
CN109776293B (en) * 2019-01-25 2022-04-05 温州大学 Method for preparing 1, 3-diketone compound from alkynone

Similar Documents

Publication Publication Date Title
CN113563370B (en) Preparation method for preparing beta-boron-based ketone with alpha-position substituent by catalysis of chitosan loaded copper material
CN103553931A (en) Method for synthesizing chiral diketone compound
CN104876971B (en) Based on Co(Ⅱ)Metal organic frame and preparation method and application
US11623907B2 (en) Method for directly constructing highly optically active tetrasubstituted allenic acid compounds
CN106632073A (en) Synthesis method of 3,4-dihydropyrimidin-2-ketone compounds catalyzed by ionic liquid at room temperature
CN110563551B (en) A method for synthesizing trans 2-en-4-yn-1-alcohol compounds
CN114456203B (en) Method for preparing β-boryl ketone by catalysis of chitosan Schiff base copper functional material
CN110950778A (en) Process and catalyst system for preparing aromatic malononitrile
CN101781222A (en) Method for preparing enamine ketone compound
CN113549062A (en) A large sterically hindered chiral quaternary ammonium salt phase transfer catalyst derived from cinchonadine and its synthesis method
CN100389877C (en) A kind of supported catalyst for preparing chiral secondary alcohol at normal pressure and preparation method thereof
CN109535120B (en) Preparation method of 7-substituted-3, 4,4, 7-tetrahydrocyclobutane coumarin-5-ketone
CN115181081B (en) A method for synthesizing β-phenyl-γ-butyrolactone
CN103665036B (en) Chiral sulfoxide-phosphine compound, preparations and applicatio
CN107721936B (en) Method for synthesizing 3,4-dihydropyrimidin-2-one compounds in water
CN105175364A (en) Method for preparing amprenavir midbody serving as anti-AIDS medicine
CN105713028A (en) Novel solid-state phase transfer catalyst based on Cd-MOF, method for preparing novel solid-state phase transfer catalyst and application thereof
D'Souza et al. Dichotomies in microwave-assisted propargyl-isomerization–Claisen domino sequences dependent on base strengths
CN107721858A (en) The method of phase transfer catalysis (PTC) β keto ester asymmetry α benzoylations
JP5544415B2 (en) Polymer-supported boron catalyst and production method of Michael addition reaction product using this catalyst
CN112979523A (en) Preparation method of chiral 1, 4-diphenyl-2-hydroxy-1, 4-dibutanone compound
CN114409714B (en) Method for synthesizing 1, 3-disubstituted plane chiral metallocene compound
CN114437140B (en) A fluorine-containing metal iridium complex and its synthesis method and application
CN113943220A (en) Photochemical synthesis method of 1, 4-dicarbonyl compound derivative
CN111662147A (en) Process for preparing diynes and analogues thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140205